ArticleCureus2025
Sporadic Diffuse Palmoplantar Keratoderma in a Pediatric Patient With Early Onset: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Palmoplantar keratoderma (PPK) encompasses a heterogeneous group of disorders characterized by hyperkeratosis of palms and soles. Sporadic cases with early childhood onset but no family history represent a diagnostic challenge. In this report, we present a case of an eight-year-old male child who presented with progressive thickening of palmoplantar skin since he was two years old, which progressed with painful fissures, ultimately resulting in restriction of mobility. The clinical examination revealed diffuse, yellow-orange hyperkeratotic plaques with well-demarcated margins and deep fissures over pressure points. On a series of follow-up visits, a complete clinical evaluation coupled with unremarkable laboratory findings ruled out syndromic associations. The diagnosis of sporadic diffuse non-transgradient PPK was made based on the inference of clinical presentation and exclusion of differential diagnoses. Treatment with low-dose acitretin (10 mg twice weekly) combined with topical keratolytic agents over three months resulted in significant clinical improvement, with marked reduction in hyperkeratosis and resolution of painful fissuring. This case highlights the importance of distinguishing isolated PPK from syndromic forms in pediatric patients. Systemic retinoid therapy proved effective in this case of early-onset sporadic PPK, significantly improving the patient's quality of life and mobility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.